Myeloma Crowd Radio brings you patient-led interviews of the world's top multiple myeloma researchers. Call in live at showtime to (347) 637-2631 ask questions and to learn about the latest innovation in simple terms patients can understand.
http://www.blogtalkradio.com/myelomacrowdradio
recommended podcasts
episode 24: Myeloma Crowd Radio: Alexander Lesokhin, MD, Memorial Sloan Kettering CC
Dr. Lesokhin shares the various types of immunotherapy and myeloma progress
episode 21: Myeloma Crowd Radio: Rafael Fonseca, MD, Mayo Clinic Scottsdale
What is STEP therapy and how might this affect multiple myeloma patients?
episode 20: Myeloma Crowd Radio: David Siegel, MD, PhD, John Theurer Cancer Center
New allo CAR T by Cellectis Coming to Myeloma Clinical Trials
episode 20: Myeloma Crowd Radio: David Siegel, MD, PhD, John Theurer Cancer Center
New allo CAR T by Cellectis Coming to Myeloma Clinical Trials
episode 19: Myeloma Crowd Radio: Yogesh Jethava, MD, University of Iowa
Low dose melphalan and high dose IV Vitamin C now in an open Multiple Myeloma clinical trial
episode 19: Myeloma Crowd Radio: Yogesh Jethava, MD, University of Iowa
Low dose melphalan and high dose IV Vitamin C now in an open Multiple Myeloma clinical trial
episode 18: Myeloma Crowd Radio: Ravi Vij, MD, Washington University
Learn more about a new monoclonal antibody called Isatuximab targeting CD38
episode 18: Myeloma Crowd Radio: Ravi Vij, MD, Washington University
Learn more about a new monoclonal antibody called Isatuximab targeting CD38
episode 17: Myeloma Crowd Radio: Dr. Robert Z. Orlowski, MD Anderson Cancer Center 2019
What's new in 2019 in multiple myeloma?
episode 17: Myeloma Crowd Radio: Dr. Robert Z. Orlowski, MD Anderson Cancer Center 2019
What's new in 2019 in multiple myeloma?